Full-Time
Clinical Solutions Manager
Alaska
Biointellisense
51-200 employees
Wearable remote patient monitoring with analytics
Compensation Overview
$120k - $170k/yr
Alaska, USA
Remote
Must reside in Alaska or relocate to Alaska.
 Medical, Clinical & Veterinary (2) |
|---|
| , |
- Bachelor's degree in a clinical or health-related field (e.g., Nursing, Health Sciences, Respiratory Therapy) and a current clinical credential/licensure (e.g., RN, RT/RRT)
- 10+ years of professional work experience in a healthcare clinical or hospital setting
- 3+ years of professional work in a clinical consulting role with a healthcare company is preferred
- Some remote patient monitoring or telehealth experience preferred
- Demonstrated strong organization, time management and project management skills
- Understanding of HIPAA requirements and compliance
- Strong communication and relationship management skills, in both pre-sales and post-sales environments
- Demonstrated ability to effectively communicate with customer, managers, clinicians/practitioners and executives on product, clinical expectations, technical integration, and business process
- Proficient in Excel, Word and PowerPoint and ability to independently produce documents
- Ability to manage and complete programs in a timely manner
- Lead complex customer implementations including reviewing customer’s use cases, determining product solutions, establishing success metrics, supporting the development of clinical workflows and implementation roadmaps
- Build customer relationships to ensure programs meet customer requirements and BioIntelliSense capabilities assuring long-term sustainability
- Train and educate customers on BioIntelliSense product offerings and value proposition
- Provide ongoing support and post-implementation improvement and optimization
- Coordinate with sales/business development, product, data science, customer care and operations teams to ensure successful customer programs
- Contribute clinical expertise to the end-to-end BioIntelliSense solution, offering support internally and externally
- Gather and analyze customer feedback to identify areas for improvement and to enhance the overall customer experience
- Evaluate program processes and outcomes to recommend and implement improvements for greater efficiency and customer satisfaction
- As needed, coordinate with the sales team to partner with customers during the sales process to understand customer needs and develop a value proposition and business case
BioIntelliSense makes remote patient monitoring possible with its BioButton wearable, which continuously tracks vital signs to support at-home care. The device is designed to be comfortable and discreet, and it sends data to analytics that help clinicians spot early signs of health issues for proactive intervention. It primarily serves hospitals, health systems, provider organizations, and payors in the U.S. and select global markets, selling wearables and providing data analytics services. Its approach centers on cost-effectiveness, ease of use, and healthcare partnerships to improve patient outcomes while reducing costs from hospital stays and emergency care.
Company Size
51-200
Company Stage
Series B
Total Funding
$82M
Headquarters
Denver, Colorado
Founded
2018
Simplify's Take
What believers are saying
- Houston Methodist expanded BioButton to 2,653 non-ICU beds in April 2024.
- iRhythm exclusive license generates recurring royalties from cardiac monitoring.
- Hicuity Health partnership taps 11 million annual monitoring hours in 2025.
What critics are saying
- iRhythm exploits licensed technology to compete in ambulatory cardiac monitoring.
- Houston Methodist concentration risks tens of thousands monitoring units.
- CMS cuts RPM reimbursements destroy payer-dependent revenue model.
What makes Biointellisense unique
- BioButton wearable automates 1,440 daily vital sign measurements per patient.
- BioDashboard AI analytics detects deterioration trends for proactive interventions.
- FDA-cleared Multi-Patient rechargeable model cuts per-patient device costs.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Biointellisense who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
HSA and Flexible Spending Accounts
Safe Harbor 401(k) Plan with 3% Employer Contribution with immediate vesting
Flexible Vacation Plans
Sick Leave
11 Company Holidays
Home Office Benefits Stipend
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 4%2 year growth
↑ 4%Top 10 Healthcare Devices and Supplies capital raises and investors in the U.S. - november 16th to december 31st, 2025. Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me. * Positron, medical technology company that engages in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America, received $2 million of development capital from investors. * TELA Bio, commercial-stage medical technology that provides innovative soft-tissue reconstruction solutions and optimizes clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy, received $4.65 million of development capital from EW Healthcare Partners and Nantahala Capital Management. * Alerje, health technology solution for individuals with severe food allergies, was acquired by SemPresto. * Applied Tissue Technologies, wound care technologies that offer treatment of common acute and chronic wounds, was acquired by New Horizon Medical Solutions. * BioIntelliSense, remote patient monitoring device that enhances healthcare delivery, raised $58.05 million of venture funding. * eLux Medical, fat removal technology that disrupts the cosmetic surgery market, raised $11.28 million through a combination of Series B and Series B-1 venture funding from investors, putting the company's pre-money valuation at $12 million. * Entirety Biomedical, high-performance absorbable metal implants that improve the quality of life with advanced bioabsorbable implant technology, raised $1.2 million of venture funding in a deal led by NuFund Venture Group, putting the company's pre-money valuation at $8.8 million. * OrthoPreserve, meniscus implant device that replaces the damaged meniscus to relieve pain, restore mobility, and prevent the accelerated arthritis development that normally accompanies a meniscectomy, raised $157,000 of venture funding in the form of convertible debt financing from investors. * RedDrop Dx, device that allows blood collection to be done quickly, painlessly, and without a trained professional, raised $7 million of seed funding in a deal led by Phase Three Product Development, Stout Street Capital and Innosphere Ventures Fund. * TYBR Health, collagen-based resorbable hydrogel that protects healing tendons and ligaments and support recovery after surgery, raised $7.14 million through a combination of Seed Prime-1 and Seed Prime-2 funding from Johnson & Johnson Innovation - JLABS, Texas Medical Center and VentureSouq, putting the company's pre-money valuation at $9.66 million. Tamara williams. Managing director. Please contact me if you have any questions or would like to discuss your capital raise:
What You Should Know:– BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, and Hicuity Health, a leading provider of tech-enabled virtual care services, today announced a strategic partnership to offer fully managed, end-to-end continuous patient monitoring to hospitals and health systems.– This partnership addresses critical infrastructure and staffing challenges faced by hospitals and health systems, empowering them to deploy proven, scalable monitoring solutions for in-hospital care, hospital-at-home programs, post-hospital discharge and chronic remote care management.BioIntelliSense and Hicuity Health Partner to Enhance Continuous Patient MonitoringBioIntelliSense is transforming continuous health monitoring and clinical intelligence for virtual care and remote patient monitoring (RPM) across in-hospital and home settings. Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multiparameter vital signs and physiological biometrics, offering an effortless user experience. The FDA-cleared BioButton® wearable, BioHub® gateways, BioMobile™ applications, BioCloud™ data services, and BioDashboard™ clinical intelligence system together create a scalable, reliable solution for continuous patient monitoring. AI-driven analytics provide clinicians with high-resolution patient trends and data-driven insights, enabling improved and safer care.Strategic Partnership with Hicuity Health· BioIntelliSense’s FDA-cleared BioButton® wearable and BioDashboard™ clinical intelligence system will integrate with Hicuity Health’s 24/7 virtual patient monitoring services.· This integration provides nurses and clinicians with actionable health insights and improved workflow efficiencies.· Hicuity Health’s services, delivering over 11 million hours of patient monitoring annually, reduce workforce burden and enhance high-acuity patient care.Advancing Scalable Continuous Care· “The combination of BioIntelliSense’s award-winning, medical-grade solution with Hicuity Health’s expertise ensures that health systems of all sizes can deploy and scale continuous care programs efficiently,” said James Mault, MD, CEO and Founder of BioIntelliSense.· The partnership addresses staffing challenges in health systems by providing a comprehensive, technology-enabled solution that enables earlier interventions, improves patient outcomes, and optimizes clinical resource utilization.Enhanced Virtual Care Capabilities· The rechargeable, wireless BioButton® wearable continuously and passively monitors patient vital signs and biometrics, automating 1,440 measurements per patient per day.· The BioDashboard clinical intelligence engine utilizes algorithmic-based analytics to track vital sign trends, securely monitored by Hicuity Health.· Hicuity Health’s clinical teams follow predefined workflows and escalation protocols in collaboration with health systems to ensure timely interventions and better patient outcomes.This collaboration offers hospitals and health systems an effective solution to initiate or expand their virtual care programs, enhancing efficiency, scalability, and patient care quality
- BioIntelliSense's FDA-cleared BioButton(R) wearable and BioDashboard(TM) clinical intelligence system will integrate with Hicuity Health's 24/7 virtual patient monitoring services.
iRhythm Technologies announced that the company has signed an exclusive license agreement with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring, ACM.
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has signed an exclusive license agreement with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring (ACM).